BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 27923652)

  • 1. MiR-211 inhibits invasion and epithelial-to-mesenchymal transition (EMT) of cervical cancer cells via targeting MUC4.
    Xu D; Liu S; Zhang L; Song L
    Biochem Biophys Res Commun; 2017 Apr; 485(2):556-562. PubMed ID: 27923652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.
    Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
    Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-374c-5p regulates the invasion and migration of cervical cancer by acting on the Foxc1/snail pathway.
    Huang Y; Huang H; Li M; Zhang X; Liu Y; Wang Y
    Biomed Pharmacother; 2017 Oct; 94():1038-1047. PubMed ID: 28810526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3.
    Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C
    Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-150-5p suppresses colorectal cancer cell migration and invasion through targeting MUC4.
    Wang WH; Chen J; Zhao F; Zhang BR; Yu HS; Jin HY; Dai JH
    Asian Pac J Cancer Prev; 2014; 15(15):6269-73. PubMed ID: 25124610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
    Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
    Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-125b Suppresses Ovarian Cancer Progression via Suppression of the Epithelial-Mesenchymal Transition Pathway by Targeting the SET Protein.
    Ying X; Wei K; Lin Z; Cui Y; Ding J; Chen Y; Xu B
    Cell Physiol Biochem; 2016; 39(2):501-10. PubMed ID: 27383536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SQLE induces epithelial-to-mesenchymal transition by regulating of miR-133b in esophageal squamous cell carcinoma.
    Qin Y; Zhang Y; Tang Q; Jin L; Chen Y
    Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):138-148. PubMed ID: 28069586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-200b inhibits epithelial-mesenchymal transition and migration of cervical cancer cells by directly targeting RhoE.
    Cheng YX; Chen GT; Chen C; Zhang QF; Pan F; Hu M; Li BS
    Mol Med Rep; 2016 Apr; 13(4):3139-46. PubMed ID: 26935796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ΔNp63α attenuates tumor aggressiveness by suppressing miR-205/ZEB1-mediated epithelial-mesenchymal transition in cervical squamous cell carcinoma.
    Zhao W; Wang H; Han X; Ma J; Zhou Y; Chen Z; Zhou H; Xu H; Sun Z; Kong B; Fang H
    Tumour Biol; 2016 Aug; 37(8):10621-32. PubMed ID: 26864590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-124 inhibits proliferation, invasion, migration and epithelial-mesenchymal transition of cervical carcinoma cells by targeting astrocyte-elevated gene-1.
    Zhang X; Cai D; Meng L; Wang B
    Oncol Rep; 2016 Oct; 36(4):2321-8. PubMed ID: 27571703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate stiffness affects epithelial-mesenchymal transition of cervical cancer cells through miR-106b and its target protein DAB2.
    Piao J; You K; Guo Y; Zhang Y; Li Z; Geng L
    Int J Oncol; 2017 Jun; 50(6):2033-2042. PubMed ID: 28498390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of Frizzled-7 expression inhibits migration, invasion, and epithelial-mesenchymal transition of cervical cancer cell lines.
    Deng B; Zhang S; Miao Y; Zhang Y; Wen F; Guo K
    Med Oncol; 2015 Apr; 32(4):102. PubMed ID: 25740178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.
    Fan Z; Cui H; Xu X; Lin Z; Zhang X; Kang L; Han B; Meng J; Yan Z; Yan X; Jiao S
    Oncotarget; 2015 Sep; 6(28):25266-80. PubMed ID: 26389681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.
    Obayashi M; Yoshida M; Tsunematsu T; Ogawa I; Sasahira T; Kuniyasu H; Imoto I; Abiko Y; Xu D; Fukunaga S; Tahara H; Kudo Y; Nagao T; Takata T
    Oncotarget; 2016 Feb; 7(7):8223-39. PubMed ID: 26882562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
    Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
    Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-137 regulates epithelial-mesenchymal transition in gastrointestinal stromal tumor.
    Liu S; Cui J; Liao G; Zhang Y; Ye K; Lu T; Qi J; Wan G
    Tumour Biol; 2014 Sep; 35(9):9131-8. PubMed ID: 25027394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4C.
    Li J; Wang Q; Wen R; Liang J; Zhong X; Yang W; Su D; Tang J
    J Cell Mol Med; 2015 Dec; 19(12):2793-805. PubMed ID: 26283050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy-mediated miR-29b expression inhibits the invasion and angiogenesis of cervical cancer.
    Li Y; Zhang Z; Xiao Z; Lin Y; Luo T; Zhou Q; Zhang X
    Oncotarget; 2017 Feb; 8(9):14655-14665. PubMed ID: 28122338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of forkhead box Q1 by microRNA-506 represses the proliferation and epithelial-mesenchymal transition of cervical cancer cells.
    Zhang M; Xu Q; Yan S; Li Z; Yan W; Jia X
    Oncol Rep; 2016 May; 35(5):3106-14. PubMed ID: 26935526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.